Patient doing well, stimulation to start in coming weeks
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/af2bb775-8ade-4820-ba70-272dd42d8565/Twitter-170104-17-NEU-504-Machado-650x450_jpg)
twitter-170104-17-neu-504-machado-650×450
Cleveland Clinic has performed the first deep brain stimulation (DBS) surgery in a patient for the purpose of restoring motor function following ischemic stroke.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
During a six-hour procedure on Dec. 19, 2016, a team led by Andre Machado, MD, PhD, implanted DBS electrodes in the cerebellum of the patient, who has severe post-stroke residual hemiparesis despite previous physical therapy. The patient has been discharged home feeling well and in stable condition.
Over the next few weeks, following adequate healing and recovery from the brain surgery, the patient will undergo physical therapy. After a few weeks of rehabilitation, the DBS device connected to the implanted electrodes will be turned on as the patient continues physical therapy. The patient will be monitored and evaluated regularly to determine whether and how DBS can enhance the effects of physical therapy.
The first-in-human operation is the initial case in an NIH-supported Cleveland Clinic trial of DBS for stroke recovery detailed previously on Consult QD.
“If this research succeeds, it is a new hope for patients who have remained paralyzed after a stroke,” says Dr. Machado, Chairman of Cleveland Clinic’s Neurological Institute and a neurosurgeon specializing in neuromodulation. “It is an opportunity to allow our patients to rehabilitate and gain function and independence. Our knowledge to date shows that deep brain stimulation can help the brain reorganize and adapt beyond what physical therapy alone can do. Our study’s goal is to boost rehabilitation outcomes beyond what physical therapy alone could achieve.”
More details about this initial case in the trial are available in a new Time magazine feature. Dr. Machado (shown in the foreground of the above photo) discusses the trial’s rationale and goals in this short Consult QD video.
Advertisement
Advertisement
Large study shows rural patients are less apt to be discharged to inpatient rehab, hampering outcomes
Updates on this fast-evolving therapeutic landscape from a leading trialist
Advanced surgical suite in our soon-to-open facility promises to redefine care standards
Two research projects aim to enable more personalized MS care in this population
Inferior clinical outcomes continue into mechanical thrombectomy era, large analysis finds
How to use? Consider starting during the acute attack and seek patient preferences for chronic use
Quantitative imaging adds diagnostic value beyond 3T MRI in nearly half of patients
Expert shares insight on intrathecal baclofen pumps to treat spasticity